Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Melinjo seed extract increases adiponectin multimerization in physiological and pathological conditions.

Oniki K, Kawakami T, Nakashima A, Miyata K, Watanabe T, Fujikawa H, Nakashima R, Nasu A, Eto Y, Takahashi N, Nohara H, Suico MA, Kotani S, Obata Y, Sakamoto Y, Seguchi Y, Saruwatari J, Imafuku T, Watanabe H, Maruyama T, Kai H, Shuto T.

Sci Rep. 2020 Mar 9;10(1):4313. doi: 10.1038/s41598-020-61148-2.

2.

Azithromycin inhibits constitutive airway epithelial sodium channel activation in vitro and modulates downstream pathogenesis in vivo.

Fujikawa H, Kawakami T, Nakashima R, Nasu A, Kamei S, Nohara H, Eto Y, Ueno-Shuto K, Takeo T, Nakagata N, Suico MA, Kai H, Shuto T.

Biol Pharm Bull. 2020 Jan 31. doi: 10.1248/bpb.b19-01091. [Epub ahead of print]

3.

Histologic Appearance and Immunohistochemistry of DNA Mismatch Repair Protein and p53 in Endometrial Carcinosarcoma: Impact on Prognosis and Insights Into Tumorigenesis.

Saijo M, Nakamura K, Ida N, Nasu A, Yoshino T, Masuyama H, Yanai H.

Am J Surg Pathol. 2019 Nov;43(11):1493-1500. doi: 10.1097/PAS.0000000000001353.

PMID:
31478942
4.

[Anaphylactic shock secondary to the use of macrogol 4000 as a bowel cleanser:a case report].

Ouchi S, Ogiyama H, Tsutsui S, Nasu A, Seto K, Horiki M, Sanomura T, Imanaka K, Murayama Y, Iishi H.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(4):330-335. doi: 10.11405/nisshoshi.116.330. Japanese.

PMID:
30971670
5.

Curcumin Down-Regulates Toll-Like Receptor-2 Gene Expression and Function in Human Cystic Fibrosis Bronchial Epithelial Cells.

Chaudhary N, Ueno-Shuto K, Ono T, Ohira Y, Watanabe K, Nasu A, Fujikawa H, Nakashima R, Takahashi N, Suico MA, Kai H, Shuto T.

Biol Pharm Bull. 2019 Mar 1;42(3):489-495. doi: 10.1248/bpb.b18-00928. Epub 2019 Jan 10.

6.

Long-term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion.

Takeda H, Nishijima N, Nasu A, Komekado H, Kita R, Kimura T, Kudo M, Osaki Y.

Hepatol Res. 2019 May;49(5):594-599. doi: 10.1111/hepr.13294. Epub 2019 Jan 31.

7.

Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Clostridium perfringens Enterotoxin.

Suzuki H, Hosomi K, Nasu A, Kondoh M, Kunisawa J.

Front Immunol. 2018 Oct 9;9:2320. doi: 10.3389/fimmu.2018.02320. eCollection 2018.

8.

Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Akahane T, Kurosaki M, Itakura J, Tsuji K, Joko K, Kimura H, Nasu A, Ogawa C, Kojima Y, Hasebe C, Wada S, Uchida Y, Sohda T, Suzuki H, Yoshida H, Kusakabe A, Tamada T, Kobashi H, Mitsuda A, Kondo M, Shigeno M, Ide Y, Morita A, Kitamura T, Abe T, Izumi N.

Hepatol Res. 2019 Mar;49(3):264-270. doi: 10.1111/hepr.13246. Epub 2018 Oct 20.

PMID:
30171740
9.

Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus.

Nishijima N, Nasu A, Kimura T, Osaki Y.

Intern Med. 2019 Jan 15;58(2):225-231. doi: 10.2169/internalmedicine.0712-17. Epub 2018 Aug 24.

10.

Immunological association of inducible bronchus-associated lymphoid tissue organogenesis in Ag85B-rHPIV2 vaccine-induced anti-tuberculosis mucosal immune responses in mice.

Nagatake T, Suzuki H, Hirata SI, Matsumoto N, Wada Y, Morimoto S, Nasu A, Shimojou M, Kawano M, Ogami K, Tsujimura Y, Kuroda E, Iijima N, Hosomi K, Ishii KJ, Nosaka T, Yasutomi Y, Kunisawa J.

Int Immunol. 2018 Sep 25;30(10):471-481. doi: 10.1093/intimm/dxy046.

11.

Prophylactic clip closure may reduce the risk of delayed bleeding after colorectal endoscopic submucosal dissection.

Ogiyama H, Tsutsui S, Murayama Y, Maeda S, Satake S, Nasu A, Umeda D, Miura Y, Tominaga K, Horiki M, Sanomura T, Imanaka K, Iishi H.

Endosc Int Open. 2018 May;6(5):E582-E588. doi: 10.1055/a-0581-8886. Epub 2018 May 8.

12.

Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.

Fujii H, Kimura H, Kurosaki M, Hasebe C, Akahane T, Yagisawa H, Kato K, Yoshida H, Itakura J, Sakita S, Satou T, Okada K, Kusakabe A, Kojima Y, Kondo M, Morita A, Nasu A, Tamada T, Okushin H, Kobashi H, Tsuji K, Joko K, Ogawa C, Uchida Y, Mitsuda A, Sohda T, Ide Y, Izumi N.

Hepatol Res. 2018 Aug;48(9):746-756. doi: 10.1111/hepr.13070. Epub 2018 May 17.

PMID:
29480939
13.

Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice.

Suzuki H, Nagatake T, Nasu A, Lan H, Ikegami K, Setou M, Hamazaki Y, Kiyono H, Yagi K, Kondoh M, Kunisawa J.

Sci Rep. 2018 Feb 13;8(1):2904. doi: 10.1038/s41598-018-21120-7.

14.

Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter.

Yamashina T, Tumura T, Maruo T, Matsumae T, Yoshida H, Tanke G, Taki M, Fukuhara M, Kimura Y, Sakamoto A, Henmi S, Sawai Y, Saito S, Nishijima N, Nasu A, Komekado H, Asada M, Kita R, Kimura T, Osaki Y.

Endosc Int Open. 2018 Jan;6(1):E111-E114. doi: 10.1055/s-0043-123467. Epub 2018 Jan 16.

15.

Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.

Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y.

Oncol Lett. 2017 Aug;14(2):1637-1647. doi: 10.3892/ol.2017.6287. Epub 2017 May 31.

16.

Cold snare polypectomy reduced delayed postpolypectomy bleeding compared with conventional hot polypectomy: a propensity score-matching analysis.

Yamashina T, Fukuhara M, Maruo T, Tanke G, Marui S, Sada R, Taki M, Ohara Y, Sakamoto A, Henmi S, Sawai Y, Saito S, Nishijima N, Nasu A, Komekado H, Sekikawa A, Asada M, Tumura T, Kita R, Kimura T, Osaki Y.

Endosc Int Open. 2017 Jul;5(7):E587-E594. doi: 10.1055/s-0043-105578. Epub 2017 Jun 23.

17.

Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing.

Takeda H, Ueda Y, Inuzuka T, Yamashita Y, Osaki Y, Nasu A, Umeda M, Takemura R, Seno H, Sekine A, Marusawa H.

Sci Rep. 2017 Mar 31;7:45605. doi: 10.1038/srep45605.

18.

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis.

Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y.

J Cancer. 2017 Feb 10;8(3):378-387. doi: 10.7150/jca.16786. eCollection 2017.

19.

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir.

Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y.

J Cancer. 2017 Jan 11;8(2):152-161. doi: 10.7150/jca.16523. eCollection 2017.

20.
21.

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.

Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y.

Medicine (Baltimore). 2016 Sep;95(36):e4832. doi: 10.1097/MD.0000000000004832.

22.

Facile Diastereoseparation of Glycosyl Sulfoxides by Chiral Stationary Phase.

Taniguchi T, Asahata M, Nasu A, Shichibu Y, Konishi K, Monde K.

Chirality. 2016 Jul;28(7):534-9. doi: 10.1002/chir.22610. Epub 2016 Jun 14.

PMID:
27296702
23.

Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience.

Endo M, Nishikawa H, Kita R, Kimura T, Ohara Y, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

Mol Clin Oncol. 2016 Apr;4(4):515-522. Epub 2016 Jan 28.

24.

Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis.

Nishikawa H, Kita R, Kimura T, Endo M, Ohara Y, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

Int J Oncol. 2015;46(6):2371-9. doi: 10.3892/ijo.2015.2969. Epub 2015 Apr 17.

PMID:
25891119
25.

Hyponatremia in hepatocellular carcinoma complicating with cirrhosis.

Nishikawa H, Kita R, Kimura T, Ohara Y, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

J Cancer. 2015 Apr 1;6(5):482-9. doi: 10.7150/jca.11665. eCollection 2015.

26.

Clinical implication of performance status in patients with hepatocellular carcinoma complicating with cirrhosis.

Nishikawa H, Kita R, Kimura T, Ohara Y, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

J Cancer. 2015 Feb 26;6(4):394-402. doi: 10.7150/jca.11212. eCollection 2015.

27.

Clinical implication of the preoperative GSA index in ⁹⁹mTc-GSA scintigraphy in hepatitis C virus-related hepatocellular carcinoma.

Nishikawa H, Osaki Y, Komekado H, Sakamoto A, Saito S, Nishijima N, Nasu A, Arimoto A, Kita R, Kimura T.

Oncol Rep. 2015 Mar;33(3):1071-8. doi: 10.3892/or.2014.3691. Epub 2014 Dec 22.

PMID:
25528990
28.

Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma.

Ikeda K, Osaki Y, Nakanishi H, Nasu A, Kawamura Y, Jyoko K, Sano T, Sunagozaka H, Uchino K, Minami Y, Saito Y, Nagai K, Inokuchi R, Kokubu S, Kudo M.

Oncology. 2014;87 Suppl 1:73-7. doi: 10.1159/000368148. Epub 2014 Nov 22. Review.

PMID:
25427736
29.

[Difficulties at work and work motivation of ulcerative colitis suffers].

Nasu A, Yamada K, Morioka I.

Sangyo Eiseigaku Zasshi. 2015;57(1):9-18. doi: 10.1539/sangyoeisei.E14002. Epub 2014 Nov 21. Japanese.

30.

Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.

Nishikawa H, Osaki Y, Komekado H, Sakamoto A, Saito S, Nishijima N, Nasu A, Arimoto A, Kita R, Kimura T.

Oncol Rep. 2015 Jan;33(1):88-94. doi: 10.3892/or.2014.3573. Epub 2014 Oct 30.

PMID:
25354477
31.

Enhanced chondrogenesis of induced pluripotent stem cells from patients with neonatal-onset multisystem inflammatory disease occurs via the caspase 1-independent cAMP/protein kinase A/CREB pathway.

Yokoyama K, Ikeya M, Umeda K, Oda H, Nodomi S, Nasu A, Matsumoto Y, Izawa K, Horigome K, Kusaka T, Tanaka T, Saito MK, Yasumi T, Nishikomori R, Ohara O, Nakayama N, Nakahata T, Heike T, Toguchida J.

Arthritis Rheumatol. 2015 Jan;67(1):302-14. doi: 10.1002/art.38912.

32.

Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients.

Nishikawa H, Kita R, Kimura T, Ohara Y, Takeda H, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

J Cancer. 2014 Jul 17;5(7):590-7. doi: 10.7150/jca.9413. eCollection 2014.

33.

Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis.

Nishikawa H, Kita R, Kimura T, Ohara Y, Takeda H, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

Int J Oncol. 2014 Sep;45(3):1082-90. doi: 10.3892/ijo.2014.2514. Epub 2014 Jun 24.

PMID:
24969042
34.

Clinical efficacy of non-transplant therapies in patients with hepatocellular carcinoma with Child-Pugh C liver cirrhosis.

Nishikawa H, Kita R, Kimura T, Ohara Y, Takeda H, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

Anticancer Res. 2014 Jun;34(6):3039-44.

PMID:
24922670
35.

[Three cases of hepatocellular carcinoma with nodules showing different signal intensities in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI].

Kita R, Sakamoto A, Iguchi E, Takeda H, Oohara Y, Nishijima N, Saito S, Nasu A, Nishikawa H, Kimura T, Osaki Y, Wakasa T, Nakanuma Y, Matsui O.

Nihon Shokakibyo Gakkai Zasshi. 2014 May;111(5):940-7. Japanese.

PMID:
24806238
36.

Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib.

Takeda H, Nishikawa H, Iguchi E, Ohara Y, Sakamoto A, Hatamaru K, Henmi S, Saito S, Nasu A, Komekado H, Kita R, Kimura T, Osaki Y.

Mol Clin Oncol. 2013 Mar;1(2):241-248. Epub 2012 Dec 3.

37.

Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy.

Nishikawa H, Enomoto H, Nasu A, Aizawa N, Saito M, Tamori A, Kawada N, Kimura T, Osaki Y, Nishiguchi S.

Hepatol Res. 2014 Dec;44(14):E397-E407. doi: 10.1111/hepr.12326. Epub 2014 May 6.

PMID:
24628684
38.

Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation.

Matsumoto Y, Hayashi Y, Schlieve CR, Ikeya M, Kim H, Nguyen TD, Sami S, Baba S, Barruet E, Nasu A, Asaka I, Otsuka T, Yamanaka S, Conklin BR, Toguchida J, Hsiao EC.

Orphanet J Rare Dis. 2013 Dec 9;8:190. doi: 10.1186/1750-1172-8-190.

39.

Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.

Nishikawa H, Osaki Y, Kita R, Kimura T, Ohara Y, Takeda H, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Nishiguchi S.

Oncol Rep. 2014 Jan;31(1):65-72. doi: 10.3892/or.2013.2845. Epub 2013 Nov 13.

PMID:
24220763
40.

[A case of α-fetoprotein-producing hepatoid adenocarcinoma of the stomach with spontaneous rupture of multiple liver metastases].

Takeda H, Kita R, Kanesaka T, Nakajima J, Matsuda F, Sakamoto A, Hatamaru K, Saito S, Nasu A, Nishikawa H, Komekado H, Sekikawa A, Tsumura T, Maruo T, Okabe Y, Kimura T, Osaki Y, Wakasa T, Nakashima O.

Nihon Shokakibyo Gakkai Zasshi. 2013 Sep;110(9):1625-32. Japanese.

PMID:
24005103
41.

Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Ohtsuru S, Ueda Y, Marusawa H, Inuzuka T, Nishijima N, Nasu A, Shimizu K, Koike K, Uemoto S, Chiba T.

J Clin Microbiol. 2013 Nov;51(11):3645-52. doi: 10.1128/JCM.00676-13. Epub 2013 Aug 28.

42.

A model of liver carcinogenesis originating from hepatic progenitor cells with accumulation of genetic alterations.

Kim SK, Nasu A, Komori J, Shimizu T, Matsumoto Y, Minaki Y, Kohno K, Shimizu K, Uemoto S, Chiba T, Marusawa H.

Int J Cancer. 2014 Mar 1;134(5):1067-76. doi: 10.1002/ijc.28445. Epub 2013 Sep 16.

43.

Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma.

Nishikawa H, Osaki Y, Takeda H, Sakamoto A, Saito S, Nishijima N, Nasu A, Arimoto A, Kita R, Kimura T.

J Gastrointestin Liver Dis. 2013 Jun;22(2):173-81.

44.

Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma.

Takeda H, Nishikawa H, Iguchi E, Ohara Y, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Kita R, Kimura T, Osaki Y.

Hepatol Res. 2014 Mar;44(3):302-12. doi: 10.1111/hepr.12125. Epub 2013 Apr 29.

PMID:
23607614
45.

Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin.

Nasu A, Ikeya M, Yamamoto T, Watanabe A, Jin Y, Matsumoto Y, Hayakawa K, Amano N, Sato S, Osafune K, Aoyama T, Nakamura T, Kato T, Toguchida J.

PLoS One. 2013;8(1):e53771. doi: 10.1371/journal.pone.0053771. Epub 2013 Jan 31.

46.

Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients.

Nishikawa H, Osaki Y, Iguchi E, Takeda H, Ohara Y, Sakamoto A, Hatamaru K, Henmi S, Saito S, Nasu A, Kita R, Kimura T.

J Gastrointestin Liver Dis. 2012 Dec;21(4):397-405.

47.

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma.

Nishikawa H, Osaki Y, Iguchi E, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Saito S, Nasu A, Kita R, Kimura T.

Exp Ther Med. 2012 Sep;4(3):381-386. Epub 2012 Jun 15.

48.

Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma.

Nishikawa H, Osaki Y, Iguchi E, Takeda H, Ohara Y, Sakamoto A, Hatamaru K, Saito S, Nasu A, Kita R, Kimura T.

Anticancer Res. 2012 Nov;32(11):5059-65.

PMID:
23155279
49.

The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.

Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T.

J Clin Gastroenterol. 2013 Apr;47(4):359-66. doi: 10.1097/MCG.0b013e31826be9ad.

PMID:
23090049
50.

Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes.

Nishikawa H, Osaki Y, Iguchi E, Takeda H, Matsuda F, Nakajima J, Sakamoto A, Hatamaru K, Saito S, Nasu A, Kita R, Kimura T.

J Gastroenterol. 2013 Aug;48(8):951-65. doi: 10.1007/s00535-012-0690-0. Epub 2012 Oct 12.

PMID:
23065022

Supplemental Content

Support Center